Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -735.69x is in line with its 5-year average of -696.65x, around the middle of its 5-year range (-2302.03x–-61.17x).
247.53% below its 12-month average of -211.69x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-04-30): -257.19x.
INTEREST COVERAGE RATIO
-735.69x
INTEREST COVERAGE RATIO AVG TTM
-211.69x
INTEREST COVERAGE RATIO AVG 3Y
-211.69x
INTEREST COVERAGE RATIO AVG 5Y
-696.65x
INTEREST COVERAGE RATIO AVG 10Y
-168.15x
INTEREST COVERAGE RATIO AVG 15Y
-154.00x
INTEREST COVERAGE RATIO AVG 20Y
-159.56x
CURRENT VS TTM AVG
-247.53%
CURRENT VS 3Y AVG
-247.53%
CURRENT VS 5Y AVG
-5.60%
CURRENT VS 10Y AVG
-337.51%
CURRENT VS 15Y AVG
-377.73%
CURRENT VS 20Y AVG
-361.08%
SECTOR MEDIAN · HEALTHCARE
-2.97x
median of 296 covered companies
CURRENT VS SECTOR MEDIAN
-24629.08%
vs the sector median at left
BriaCell Therapeutics Corp.
Market Cap
$36.37M
Interest Coverage Ratio
-735.69x
TTM Avg
-211.69x
3Y Avg
-211.69x
5Y Avg
-696.65x
Market Cap
$36.32M
Interest Coverage Ratio
47.58x
TTM Avg
47.58x
3Y Avg
47.58x
5Y Avg
47.58x
Market Cap
$36.31M
Interest Coverage Ratio
N/A
TTM Avg
8.27x
3Y Avg
8.27x
5Y Avg
8.27x
Market Cap
$36.61M
Interest Coverage Ratio
-33.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.05M
Interest Coverage Ratio
-87.92x
TTM Avg
13.24x
3Y Avg
16.68x
5Y Avg
16.68x
Market Cap
$35.89M
Interest Coverage Ratio
-0.75x
TTM Avg
0.33x
3Y Avg
0.47x
5Y Avg
0.65x
Market Cap
$37.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.34M
Interest Coverage Ratio
-0.13x
TTM Avg
0.53x
3Y Avg
0.64x
5Y Avg
0.43x
Market Cap
$33.52M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | $36.37M | -735.69x | -211.69x | -211.69x | -696.65x |
| Elutia Inc (ELUT)vs › | $36.32M | 47.58x | 47.58x | 47.58x | 47.58x |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | N/A | 8.27x | 8.27x | 8.27x |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.61M | -33.29x | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $36.05M | -87.92x | 13.24x | 16.68x | 16.68x |
| Accuray Incorporated (ARAY)vs › | $35.89M | -0.75x | 0.33x | 0.47x | 0.65x |
| Edesa Biotech, Inc. (EDSA)vs › | $37.67M | N/A | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.34M | -0.13x | 0.53x | 0.64x | 0.43x |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | N/A | N/A | N/A | N/A |
Interest Coverage
-735.7x
Debt/Equity
0.00
Current Ratio
7.07
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-04-30 | -257.19x |
| 2025-04-30 | -166.19x |
| 2021-10-31 | -2302.03x |
| 2021-04-30 | -61.17x |
| 2021-01-31 | -3.38x |
| 2020-10-31 | -19.77x |
| 2020-07-31 | -24.95x |
| 2020-04-30 | -100.64x |
| 2020-01-31 | -360.00x |
| 2019-10-31 | -520.37x |
| 2019-07-31 | -276.22x |
| 2019-04-30 | -347.46x |
| 2019-01-31 | -138.09x |
| 2018-10-31 | -73.84x |
| 2018-04-30 | -4.89x |
| 2015-07-31 | -131.06x |
| 2015-04-30 | -103.74x |
| 2014-10-31 | -28.97x |
| 2009-04-30 | -82.63x |
| 2009-01-31 | -331.02x |
| 2007-01-31 | -847.49x |
